Objective: Glycogen in astrocyte processes contributes to maintenance of low extracellular glutamate and K 1 concentrations around excitatory synapses. Sleep deprivation (SD), a common migraine trigger, induces transcriptional changes in astrocytes, reducing glycogen breakdown. We hypothesize that when glycogen utilization cannot match synaptic energy demand, extracellular K 1 can rise to levels that activate neuronal pannexin-1 channels and downstream inflammatory pathway, which might be one of the mechanisms initiating migraine headaches. Methods: We suppressed glycogen breakdown by inhibiting glycogen phosphorylation with 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) and by SD. Results: DAB caused neuronal pannexin-1 large pore opening and activation of the downstream inflammatory pathway as shown by procaspase-1 cleavage and HMGB1 release from neurons. Six-hour SD induced pannexin-1 mRNA. DAB and SD also lowered the cortical spreading depression (CSD) induction threshold, which was reversed by glucose or lactate supplement, suggesting that glycogen-derived energy substrates are needed to prevent CSD generation. Supporting this, knocking down the neuronal lactate transporter MCT2 with an antisense oligonucleotide or inhibiting glucose transport from vessels to astrocytes with intracerebroventricularly delivered phloretin reduced the CSD threshold. In vivo recordings with a K 1 -sensitive/selective fluoroprobe, Asante Potassium Green-4, revealed that DAB treatment or SD caused a significant rise in extracellular K 1 during whisker stimulation, illustrating the critical role of glycogen in extracellular K 1 clearance. Interpretation: Synaptic metabolic stress caused by insufficient glycogen-derived energy substrate supply can activate neuronal pannexin-1 channels as well as lower the CSD threshold. Therefore, conditions that limit energy supply to synapses (eg, SD) may predispose to migraine attacks, as suggested by genetic studies associating glucose or lactate transporter deficiency with migraine.
transmission appears so fundamental that even under conditions where the energy production via glucose breakdown is sufficient, glycogen is still required for glutamate uptake. 8 Increased extracellular K 1 , glutamate, and adenosine triphosphate (ATP) concentrations and intracellular Ca 21 rises can activate neuronal pannexin-1 (Panx-1) channels. [9] [10] [11] [12] [13] The above conditions are present during cortical spreading depression (CSD), the putative cause of migraine aura. 14, 15 CSD has been shown to activate neuronal Panx-1 channels in the mouse brain in vivo, and this has been proposed as a potential mechanism initiating a parenchymal-meningeal inflammatory cascade that leads to activation of meningeal trigeminal afferents, and hence, headache following migraine aura. 16, 17 As similar conditions may emerge around intensely active excitatory synapses when glycogen-derived glucose and lactate cannot match the increased energy demand for restoration of the transmembrane gradients of glutamate, K
1
, and Ca 21 , we hypothesize that neuronal Panx-1 channels can be activated, and this might be one of the potential mechanisms by which sleep deprivation, a well-known migraine trigger, 18 can initiate the inflammatory cascade leading to headache without requiring aura (ie, without CSD). Sleep deprivation (ie, extended wakefulness) induces astrocytic expression of the enzyme PTG (protein targeting to glycogen), a noncatalytic subunit of the protein phosphatase-1 that results in an increased activity of glycogen synthase, the enzyme responsible for incorporation of glucose into glycogen. [19] [20] [21] Therefore, sleep deprivation may limit the capacity to maintain low extracellular glutamate and K 1 concentrations during sustained excitatory transmission by driving glycogen metabolism toward synthesis rather than its utilization as a glucose and lactate source. Hence, a decreased capacity for such compensation (eg, due to genetic predisposition or hormonal factors) may make some migraineurs more vulnerable to changes in sleep rhythm either by predisposing to synaptic conditions that can activate large pore channels such as neuronal Panx-1/P2X7 complex and the downstream inflammatory cascade (migraine without aura) or by lowering the threshold for CSD generation (migraine with aura). 16, 17 In both cases, Panx-1 channels may serve as sensors that detect the neuronal stress induced by metabolically uncoupled synaptic transmission or CSD and initiate the inflammatory cascade that can potentially activate the trigeminal system. To test these hypotheses, we have investigated whether the impairment of glycogen-derived energy supply to synapses can directly activate Panx-1 channels or lower the CSD induction threshold in the mouse cortex in vivo. To reduce glycogen mobilization, we used a pharmacological inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-D-arabinitol (DAB). Because the energy metabolite transferred from astrocytes to neurons upon glycogen breakdown is lactate, 22 we also used an antisense oligodeoxynucleotide (ODN) for the neuronal monocarboxylate transporter MCT2. 4 Finally, we induced sleep deprivation of 6 hours to reduce glycogen availability for supporting excitatory synaptic transmission. We have found that these approaches reducing glycogen mobilization can initiate an inflammatory cascade downstream to Panx-1 complex by directly triggering caspase-1 cleavage and HMGB1 release from neurons even in the absence of CSD. 16 We have also found that insufficient glycogen-derived synaptic energy supply can reduce the CSD threshold.
Materials and Methods

Animals, Surgery, and Intracerebroventricular Injections
Swiss albino mice (n 5 209) weighing 25 to 36g were housed under diurnal lighting conditions (12 hours darkness and 12 hours light) and fed ad libitum before the experiment. Animal housing, care, and application of experimental procedures were all carried out in accordance with the institutional guidelines and approved by the Hacettepe University Animal Experiments Local Ethics Committee (2009/38-2). Animals were anesthetized with urethane/xylazine (1.25g/kg and 10mg/kg, intraperitoneal) during the experiments. Brief isoflurane (1-2%) anesthesia was used for intracerebroventricular (i.c.v.) cannula placement a day before the experiment. Oxygen (2l/min) was supplied throughout the procedure. Body temperature was kept at 37.0 6 0.18C with a homeothermic blanket and a rectal probe. Tissue oxygen saturation and pulse rate were monitored with a pulse oximeter. Mice were placed in a stereotactic frame after the induction of deep anesthesia. A frontal burr hole was drilled over the right hemisphere for CSD induction with an epidural KCl-soaked cotton ball. For i.c.v. injections of propidium iodide (PI), DAB, and carbenoxolone (CBX), a Hamilton syringe with a 26-gauge needle was slowly inserted through the cannula placed a day before the experiment, except for the CSD-induction threshold experiments. For the threshold experiments, DAB or phloretin was slowly injected into the left ventricle with help of a micromanipulator within 8 to 10 minutes at the coordinates 0.1mm posterior, 0.9mm lateral, 3.1mm deep with reference to bregma. DAB (0.25M, 0.75 ml, dissolved in saline; SigmaAldrich, St Louis, MO) or saline (0.75 ml) was injected 1 h before the threshold test. During the 1-h waiting period, direct current (DC) potential changes were continuously monitored. Phloretin (2M, 1 ml; dissolved in dimethylsulfoxide [DMSO]; Sigma-Aldrich) or DMSO (1 ml) was injected 30 minutes before threshold experiments. All solutions were heated to 378C before injection.
PI Injection
We assessed the opening of Panx-1 channels with PI after DAB administration. PI is a membrane-impermeable dye; however, it can pass through large pore channels when they are open and give fluorescence by interacting with nucleic acids after entering the cell. A 1mm-thick (outer diameter) polyethylene cannula was slowly inserted 2.1mm deep into the left lateral ventricle through a burr hole drilled over the left parietal bone under isoflurane anesthesia. The day after cannula implantation, animals were placed in a stereotaxic frame under urethane/xylazine anesthesia. PI (0.5 ml, 1mg/ml in distilled water) was injected with a 26-gauge needle on a Hamilton syringe slowly inserted through the cannula by a micromanipulator 55 minutes after DAB or saline (as control for DAB experiments) injection. The tip of the needle was adjusted to target the ventricle 3.1mm deep with reference to dura. Mice were sacrificed by transcardial perfusion with heparinized saline and 4% paraformaldehyde (PFA) 1 hour after DAB/saline injection (n 5 3 in each group). Brains were quickly removed and kept in 4% PFA overnight followed by 30% sucrose for 2 days. Twenty-micrometerthick sections were cut on a freezing cryostat and mounted in glycerol/phosphate-buffered saline (PBS; 1:1) medium containing 12.5mg/ml sodium azide and 1 ll/ml Hoechst-33258. PI fluorescence was evaluated on 3 consecutive images of coronal brain sections under 3400 magnification with appropriate filter sets using a fluorescence microscope (E600; Nikon, Tokyo, Japan).
CBX Injection
To inhibit Panx-1 channels, 400ng CBX (in 2 ml distilled water, n 5 3) was slowly injected into the left lateral ventricle with the needle of a Hamilton syringe driven by a micromanipulator through a polyethylene cannula placed a day before as described above. An equal volume of distilled water (n 5 3) was injected to control animals. After 10 minutes, PI was slowly injected through the same cannula as described above to monitor Panx-1 activation in both groups. Mice were sacrificed by transcardial perfusion with heparinized saline and 4% PFA 5 minutes after PI injection, and the above tissue-processing protocol was applied for cryoprotection, sectioning, and evaluation of the PIpositive cells.
Immunohistochemistry
Because caspase-1 is reportedly cleaved 5 minutes after Panx-1 activation, 16 mice were sacrificed 65 minutes after DAB/saline injection (n 5 3/group). After cryoprotection, 40-mm-thick coronal sections were cut on a sliding microtome. As HMGB1 is reportedly released 30 minutes after Panx-1 activation, another set of mice was sacrificed 90 minutes after DAB injection. These mice were transcardially perfused with heparinized saline and 4% PFA. Brains were quickly removed, postfixed in the same solution overnight, and cryoprotected in 30% sucrose solution for 2 days. Twenty-micrometer-thick coronal sections were cut on a freezing cryostat. 
Whisker Stimulation
Whiskers on the left side were stimulated with a custom-made brush driven by a motor at a rate of 10Hz for 5 minutes. These stimulation parameters were first shown to induce a robust cortical blood flow (CBF) increase in the contralateral barrel cortex by laser speckle imaging.
Electrophysiological Recordings
For extracranial recording of DC potentials, 2 Ag-AgCl pellet electrodes (Warner Instruments, Hamden, CT; E205, 1mm diameter) were placed over the thinned skull.
Electroencephalographic gel was applied to the electrode tip to obtain good electrical contact. For intracortical recordings, a cranial window (2mm in diameter) was opened over the parietal cortex and its borders were sealed with dental cement. Two 0.5M NaCl-filled borosilicate glass microelectrodes were used for intracortical recordings. Microelectrodes were prepared by pulling glass capillaries (Harvard Apparatus, Holliston, MA; GC150F-10) with a horizontal puller (David Kopf Instruments, Tujunga, CA), and then the tips were broken into 5 to 10 mm so that the impedance would be 0.5 to 1MOhm. A chlorinated silver wire (Warner Instruments, AG15W, 0.375mm diameter) was inserted into the glass microelectrodes. The tips of the microelectrodes were lowered 400 mm deep into the cortex with a micromanipulator (Narishige, Tokyo, Japan; MMO220A). An Ag-AgCl-plated disk electrode was placed under the neck muscles to be used as the ground lead. All the electrodes were connected to a data acquisition system (Powerlab 8/30; ADInstruments, Bella Vista, Australia) via gold pins and jacks (Warner Instruments, WC1-10 and PJ1-10). Signals were digitized, displayed, and stored on a computer.
Assessment of the CSD Threshold
Cotton balls soaked with increasing concentrations of KCl (0.05, 0.075, 0.1, 0.15, 0.25M) were applied on intact dura over the frontal cortex 5 minutes apart. The first concentration that induced a CSD was taken as the threshold. During preliminary experiments, we observed that the KCl-induced CSD threshold was dependent on the location of the burr hole where the KCl-soaked cotton ball applied, and it could be lowered by dural damage and bleedings. Therefore, we discarded animals even with a minor dural damage, and used a standard location and size for the cotton ball. KCl was applied with a calibrated micropipette in a fixed volume (10 ml). To obtain a highly reproducible threshold, we also used male mice and allowed them free access to food until the experiment to minimize potential variations that might be caused by hormonal changes and fasting.
Glucose and Lactate Superfusion
After intracortical placement of glass electrodes, 10 ml of either D-glucose (0.5M; Sigma, Saint-Quentin-Fallavier, France), Lglucose (0.5 M; Sigma, Dorset, UK), L-lactate (0.5 M; Sigma, Buchs, Switzerland), or D-lactate (0.5 M; Sigma, Buchs, Switzerland) was applied for 10 minutes before recordings. The solutions were left over the dura through the entire recording. In these experiments, the CSDs were recorded by intracortical electrodes because intracortical electrodes allowed recording more focally from the cortex superfused and also eliminated the possibility of contact of the surface pellet electrodes with the superfusion fluid leaking through the cranial window despite measures taken.
Antisense Knockdown of MCT2
MCT2 antisense ODN (MCT2-ODN; 5 0 -GACTCTGATGG-CATTTCTGAG-3 0 ) and relative scrambled ODN (SC2-ODN;
, which showed no homology to any mammalian sequence, were previously used in the brain in vivo with success by Suzuki et al. 4 To protect
ODNs from nuclease degradation, ODNs were phosphorothioated on the 3 terminal bases at each end. ODNs were purchased from Gene Link (Hawthorne, NY, USA) as reverse phase cartridge-purified. ODNs were dissolved in PBS, pH 7.4. After anesthesia, 4nmol/ml of ODN solution was injected intracortically 1mm deep at 2 different points at a rate of 0.1 ml/ min by a 26-gauge Hamilton syringe. Coordinates of the injection sites were: 0.5mm posterior, 2mm lateral to bregma, and 1mm anterior, 2mm lateral to lambda. The needle was removed slowly over 5 minutes to allow for the diffusion of the ODNs into cortical layers. The CSD threshold was assessed with the above protocol 1 hour after injection.
Sleep Deprivation
Mice were housed in a reverse 12-hour light-dark cabinet, and they were kept in this condition for at least 1 week for adjustment. On the day of the experiment, mice were kept awake for 6 hours from the beginning of the light period using the "gentle sleep deprivation" (GSD) method described by Tobler et al. 24 Briefly, animals were kept awake by providing new nesting material or new objects into their home cage when they adopted a sleeping posture of >5 to 7 seconds of immobility. Mice were not touched or stimulated by moving the cage to avoid stress as far as possible (hence, this method of keeping mice awake is called gentle). Control mice were left undisturbed in their home cages and sacrificed at the same time point. These mice were used in experiments to test the CSD threshold.
For detecting sleep deprivation-induced Panx transcription, 14 adult male C57BL6/j mice (8-10 weeks old, 22-25g; Charles River, Saint-Germain-Nuelles, France) were single housed in their home cage with a 12-hour light/dark cycle (lights on at 07:00, Zeitgeber time 0 [ZT0]) in standard conditions (temperature at 23 6 18C, food and water ad libitum). Following 7 days of habituation, mice were randomly divided into 2 groups (n 5 7 per group). One group underwent a 6-hour GSD beginning at ZT0 (SD6 group), and in the other group mice were left undisturbed for 6 hours (ZT6). Mice of each group were alternatively sacrificed by decapitation. These experiments were performed at the Brain Mind Institute in Lausanne, Switzerland by J.-M.P. according to the European Community's Council Directive (86/609/EEC) and with the authorization of the veterinary services of the Canton of Vaud (No. 224).
Panx Gene Expression Analysis
For each mouse, brain was rapidly dissected out on ice and cerebral cortex was homogenized (Ultraturax; IKA, Staufen, Germany) in ice-cold TRIzol and stored at 2808C until RNA extraction. Total RNA was extracted from tissue samples according to the TRIzol manufacturer's protocol. The concentration of each sample was measured with NanoDrop (NanoDrop Technologies, Wilmington, DE), and the purity was assessed using the ratios of optic density at 260/280 nm and 260/ 230 nm.
The first strand of cDNA was synthesized from 200ng of total RNA using TaqMan RT reagents (Applied Biosystems, Foster City, CA) after incubation for 45 minutes at 488C followed by 5 minutes at 958C and finally stored at 48C. Then, 2 ll of RT reagents were added to 0.5 ll of forward and reverse primers and to 23 ll of Sybr-Green PCR MasterMix (Applied Biosystems) following the manufacturer's instructions. Forty cycles of amplification were then performed in an ABI Prism 7900 (Applied Biosystems) with 384-well plate, which allowed the analysis of 3 genes simultaneously including b-actin for normalization in each plate. Each RT (from the cortex of 1 animal) was tested in triplicate. Primer sequences were designed using Primer Express 
Detection of Extracellular K 1 by Asante Potassium Green-4 Fluoroprobe
To detect the extracellular K 1 changes after DAB injection or GSD, a set of experiments was performed with a fluorescent potassium indicator, Asante Potassium Green (APG)-4 (TEF Labs, Austin, TX). APG-4 was prepared in 2% DMSO and artificial CSF (aCSF) to yield a final concentration of 250 lM. Anesthetized (urethane) mice were placed in a stereotactic frame. A cranial window was opened over the right barrel cortex leaving dura mater intact, sealed with dental acrylic, and filled with aCSF to form a pool and closed with a coverslip. After obtaining baseline fluorescent images under a stereomicroscope (SMZ 1000; Nikon, Tokyo, Japan), the aCSF was replaced with APG-4 solution for 1 hour. At the end of the 1-hour incubation period, the dye was washed out by irrigating with aCSF and then the cranial window was refilled with aCSF. Subsequently, whiskers on the left side were stimulated at 10Hz for 5 minutes. Time series images were taken for 30 seconds before stimulation, 5 minutes during stimulation, and 1.5 minutes after the end of stimulation. This cycle of imaging was repeated 3 times with 5-minute intervals. Epifluorescent imaging was performed with 488/517nm excitation and 540nm emission filter sets by a monochrome DS-Qi1mc CCD camera (Nikon) set at 250-millisecond exposure time. Images were captured with NIS Elements Software (Nikon). This whisker stimulation protocol was performed on 3 groups (n 5 3 mice per group): naive mice, DAB-treated mice (incubation with solution containing 0.25M DAB in 250 mM APG-4 for 1 hour), and mice subjected to 6-hour GSD. Baseline images obtained before APG-4 application were subtracted mathematically from all time series images, and every 10 subtracted images were averaged by NIS Elements 3.2 AR to minimize the pulsation artifacts. Two regions of interest were chosen over barrel cortex, and fluorescent intensity changes were calculated by dividing all images by basal fluorescent intensity (DF/Fo). In a separate group of mice treated with topical DAB in APG-4 solution or only APG-4 solution through a cranial window over right parietal cortex, we measured the duration of APG-4 fluorescence increase during passage of a CSD wave evoked by KCl (1M; n 5 3/group). 
Statistical Analyses
Results
Inhibition of Glycogen Use Opens Neuronal Panx-1 Channels
We used a well-characterized glycogen phosphorylase inhibitor, DAB, to suppress glycogen use during synaptic activity in mice under anesthesia. We examined Panx-1 activation 1 hour after i.c.v. administration of DAB (0.25M in 0.75 ml) slowly injected within 10 minutes with a micromanipulator through a cannula placed 1 day prior to the experiment to minimize the effect of any potential injection-induced injury. It had been established that 1 hour was required for an effective suppression of glycogen use in astrocytes by DAB. 4, 25 The membrane impermeable fluorescent agent PI was slowly administered i.c.v. 1 hour after DAB through the same cannula to monitor Panx-1 channel activation as large pore openings allow fluorescent dyes smaller than 1KDa to enter the cell as shown in vivo as well as in vitro. 16, 26, 27 Five minutes were allowed for distribution and detectable influx of PI to cells before sacrifice by intracardiac perfusion fixation, which terminates cellular activities in situ, and hence, prevents changes in the brain that might be induced by anoxia and hypoperfusion during sacrifice. The inhibition of glycogen use by DAB (but not i.c.v. saline injection) led to widespread PI influx to neurons (NeuN1 cells) in cortical and subcortical areas (n 5 3; Fig 1) . The intensity of labeling paralleled DAB distribution after i.c.v. injection, being more intense on the injection side hemisphere as well as in neurons closer to the injected ventricle. In the sham group, we found PI labeling only around the cannula tract but not other brain areas in animals that were subjected to the same procedures except DAB injection (n 5 3). Further supporting the connection between DAB and activation of Panx-1 channels, CBX; (slowly administered i.c.v. through the cannula 10 minutes before PI) completely inhibited PI influx in another set of DAB-injected mice (n 5 3). The i.c.v. dose of CBX used had previously been shown to block Panx-1 channels without affecting gap junction communication in the mouse brain in vivo. 16, 28 DAB injection also caused activation of the downstream inflammatory pathway from Panx-1 as shown by appearance of the cleaved active form of caspase-1 and loss of nuclear HMGB1 staining in neurons with immunohistochemistry (n 5 3 for each group) as well as by release of HMGB1 to CSF as detected with Western blotting (CSF from 3 mice were pooled each for DAB and saline injection groups).
Inhibition of Glycogen Use by DAB or Sleep Deprivation Lowers CSD Threshold
We observed spontaneous CSDs in 3 of 8 mice within 24 to 55 minutes after DAB administration, possibly caused by reduced uptake of K 1 and glutamate to astrocytes. 14 Accordingly, we investigated the effect of DAB on the CSD induction threshold in mice in which spontaneous CSDs were not observed during continuous DC potential recordings starting after DAB injection. Moreover, the CBF response recorded by laser speckle determined whether any CSDs had preceded the one evoked by KCl, as CBF responses to the first and second CSDs are clearly distinguishable in the mouse. 29 We used increasing concentrations of KCl to detect the CSD induction threshold, because we obtained a highly reproducible threshold value at 0.15M KCl in naive control mice, unlike the highly variable threshold observed with electrical stimulation reported by several laboratories. [30] [31] [32] [33] Strictly applying the measures described in Materials and Methods, we were able to evoke the first CSD with 0.15M KCl in every mouse in the control group (n 5 15). After establishing a highly reproducible normal standard, we tested the effect of DAB on the CSD induction threshold and modulation of this action by glucose and lactate in groups of 6 mice in which no spontaneous CSD was observed. We found that i.c.v. injection of DAB (0.25M in 0.75 ml saline) with a high precision micromanipulator slowly over 8 to 10 minutes 1 hour prior to the test significantly lowered the CSD threshold to 0.075M KCl compared to i.c.v. vehicleinjected sham controls (threshold 5 0.15M, p 5 0.001; Fig 2B) . Next, we investigated whether the synaptic energy insufficiency caused by preventing glycogenolysis could be reversed by superfusing the cortex with concentrated glucose solution (0.5M) starting 10 minutes before recording. As glucose could penetrate through the dura, we did not remove the dura to maintain the cortical physiology. D-Glucose (0.5M) completely reversed the DAB-induced threshold drop, suggesting that the effect of DAB was due to lack of sufficient energy substrate to match the energy demand for clearing extracellular K 1 and glutamate and preventing synchronized depolarization, leading to CSD. The effect of glucose was not due to an increased osmolarity, because superfusion with L-glucose of the same concentration failed to reverse the DAB effect. Superfusion with an equimolar concentration of L-lactate (0.5M) also reversed the effect of DAB, whereas its optical isomer was ineffective. On an equicaloric basis, glucose (0.25M) was less effective in reversing DAB's effect possibly because, unlike lactate, it is preferentially used for glycogen synthesis before being used as a fuel owing to significant differences in the reaction rates of enzymes involved in glycogen synthesizing and glycolytic pathways. 34 Further supporting the important role of lactate as an energy substrate needed to prevent synchronized depolarization and CSD, knocking down MCT2 with an antisense ODN injected intracortically where recordings were performed significantly lowered the CSD induction threshold. The control scrambled antisense oligonucleotide had no significant effect (n 5 6 each for ODN and scrambled ODN groups; see Fig 2C) . The ODN sequence used and injection 1 hour before the synaptic activity had been previously established to reduce expression of MCT2 by Western blotting and to impair long-term memory formation. 4 Because GSD hampers glycogen use by inducing transcriptional changes in several enzymes and proteins involved in glycogen metabolism in astrocytes, [19] [20] [21] we next tested whether GSD of 6 hours, a physiological disturbance, could also modify the CSD threshold. The term "gentle" here refers to gentle stimulation of the animal to keep it awake without inducing stress; hence, GSD of 6 hours duration is highly reminiscent of a common form of lack of sleep (insomnia) in humans. GSD significantly reduced the CSD induction threshold compared to the control group (p 5 0.001). This effect was reversed by 3 hours of sleep and also by D-glucose or Llactate superfusion, suggesting that the sleep deprivationinduced suppression of glycogen use caused the threshold change by leading to synaptic energy substrate deficiency (n 5 6 for each group; see Fig 2D) . Because GSD induces rapid transcriptional changes in several genes involved in glycogen metabolism, which may create stress on excitatory transmission by hampering K 1 and glutamate clearance, we also looked at the expression level of mRNAs encoding Panx-1 (a stress sensor) and Panx-2 in the cortex at the end of 6 hours of GSD. Compared with circadian control at ZT6 (ie, 6 hours after the beginning of the light period), Panx-1 mRNA expression was significantly induced by 12 6 2.8% (p < 0.0001), whereas the mRNA encoding Panx-2 exhibited no significant changes (22 6 1.3%; see Fig 2E) .
Clearance during Synaptic Activity
We have adapted a recently developed K 1 -fluoroprobe (APG-4) to monitor extracellular K 1 changes during whisker stimulation in vivo through a cranial window. First, we monitored the K 1 rise during whisker stimulation over the barrel cortex area, which displayed little change in fluorescence (0.15 6 0.04% increase). However, in the presence of DAB, APG-4 fluorescence intensity changed from a hardly noticeable rise to a robust increase (7.9 6 0.6%) during whisker stimulation. This confirms that K 1 uptake was significantly slowed during synaptic activity when glycogen mobilization was inhibited by DAB. Similarly, a striking K 1 rise (4.8 6 1.3% increase in fluorescence intensity) was observed during 5-minute whisker stimulation in sleep-deprived mice tested at the end of 6-hour GSD (Fig 3A-C) . In line with these findings, both DAB and GSD prolonged the duration of CSDs without changing the CSD propagation speed and frequency (Table) . We confirmed that prolongation of the CSD duration was caused by an extended K 1 rise during CSD by comparing APG-4 fluorescence intensity change during CSD evoked by KCl (1M) in DABtreated and untreated control mice (333 6 28 vs 162 6 11 seconds, p 5 0.05; see Fig 3D , E and Table) .
Inhibition of Vascular Glucose Transport
Lowers CSD Threshold Next, we specifically tested the effect of inhibition of glucose transport from blood into astrocytes on the CSD threshold, as glucose is necessary for glycogen synthesis. Because systemic administration of insulin has several peripheral and central actions other than reducing glucose supply to brain, 35 we chose to directly inhibit glucose transport to the brain from the abluminal surface of the endothelium, and selectively reduce glucose supply to astrocytes and neurons by i.c.v. administration of glucose transport protein type-1 (GLUT-1) inhibitor phloretin without significantly compromising endothelial metabolism. 36 Unlike its vehicle (DMSO, 1 ml), phloretin (2M in 1 ml) significantly lowered the CSD threshold 30 minutes after i.c.v. injection, suggesting that a constant supply of glucose to astrocytes and neurons is needed to prevent CSD generation (n 5 6 for each group; see Fig  2F) . Interestingly, contrary to their deficiency illustrated by several approaches above, excess glucose and lactate supplementation had no effect on the CSD threshold. Naive animals superfused with D-glucose or L-lactate did not show significantly different thresholds when compared to the control group (p 5 0.317 and p 5 0.317, respectively; see Fig 2B) , suggesting that under resting conditions synaptic energy metabolism is balanced not to allow CSD generation (n 5 6 for each group).
Discussion
Our data show that inhibition of glycogen use in the intact brain in vivo causes Panx-1 large pore channel opening in neurons. Glycogen granules in perisynaptic astrocyte endfeet around excitatory synapses are used for uptake of glutamate and K 1 released during synaptic activity. 8, 37, 38 idea. The predisposition to CSD generation created by DAB or sleep deprivation is likely to be caused by insufficient energy supply during synaptic activity, because the CSD threshold drop was completely reversed by supplying extra lactate or glucose to the interstitium. Similarly, the lower CSD threshold observed after inhibition of glucose transfer to astrocytes with phloretin or knocking down MCT2, the transporter that supplies lactate to preand postsynaptic compartments, is in line with the idea that an insufficient energy supply to match synaptic activity leads to uncontrolled synchronous excitability. 51, 52 Decrease in the CSD threshold induced by knocking down MCT2 suggests that sufficient energy supply to pre-and postsynaptic compartments is important to prevent CSD generation in addition to maintaining low extracellular glutamate and K 1 concentrations.
Restoration of the reduced CSD threshold induced by insufficient glycogen availability with lactate as well as glucose conforms with the view that glycogen is used to match the rapidly emerging energy demand during intensive synaptic activity by supplying lactate as well as glucose to pre-and postsynaptic compartments. 53 It appears so that the finetuning of the excitatory synapses terminating on excitatory as well as inhibitory neurons within a network to prevent synchronized network depolarization (which may spread to the neighboring networks once generated) is energy dependent such that insufficient acceleration of energy substrate supply from perisynaptic astrocyte processes may lead to buildup of glutamate and K 1 concentrations to supranormal levels in the synaptic cleft, favoring synchronized excitation in cortical networks, as observed in FHM knockin animals. Altogether, these observations with DAB, sleep deprivation, MCT2 knockdown, and phloretin conform with the hypothesis that glycogen in astrocyte processes is strategically positioned to secure the energy demand required for rapid removal of glutamate and K 1 from synaptic cleft (see Fig 2G) . 54 Glucose transported from the circulation can then be directly metabolized by astrocytes and used to restore the glycogen stores. 55 This metabolic safety system over the excitatory synaptic activity may ensure that the cortical networks sustain their activity in a desynchronized state. Given the importance of CSD in the development of migraine aura and headache, therefore, an adequate glycogen turnover appears to be critical such that an insufficient mobilization of glycogen created by for example sleep deprivation or conditions that reduce glucose transport to the brain, such as GLUT-1 deficiency syndrome, 56 may predispose to CSD generation and headache (migraine with aura). 16 Interestingly, when K 1 and glutamate accumulation caused by insufficient glycogen availability induces Panx-1 activation without CSD, then the inflammatory cascade downstream from Panx-1 activation may trigger headache without aura. Supporting this view, several cases of GLUT-1 deficiency syndrome have been reported to suffer from migraine with and without aura attacks, which were successfully prevented with ketogenic diet. 56, 57 Similarly, patients with monocarboxylate transporter 1 (which transports lactate from astrocyte to synapses) deficiency have been reported to have migraines. 58 Therefore, our results may have important clinical implications. The genetic findings from familial monogenic disorders can be extended to nonfamilial migraine cases by including several other genes involved in synaptic energy metabolism. Several biological factors on a genetically susceptible background may account for why insufficient sleep triggers migraine to varying degrees among patients. Ketogenic diet could be tested on sleep-deprived patients to see whether it prevents migraine attacks by providing ketone bodies as alternative energy substrates for synaptic transmission. Similarly, the effect of glucose supplement or ketogenic diet on reducing the photosensitivity in migraine patients could also be tested.
In conclusion, our findings demonstrate how Panx-1 channels can be activated and upregulated under stressful metabolic conditions during synaptic activity and suggest that migraine with and without aura could be triggered by synaptic metabolic stress.
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